Marc H. Hedrick
CIK: 0001203672
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CERENOME, INC.
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Oct 1, 2026CNSY
CERENOME, INC.
Exercise(M)Direct2K shares- - Oct 1, 2026CNSY
CERENOME, INC.
Exercise(M)Direct8.1K shares- - Oct 1, 2026CNSY
CERENOME, INC.
Exercise(M)Direct6.4K shares- - Jul 1, 2026PSTV
PLUS THERAPEUTICS, INC.
Exercise(M)Direct2K shares- - Jul 1, 2026PSTV
PLUS THERAPEUTICS, INC.
Exercise(M)Direct6.4K shares- - Jul 1, 2026PSTV
PLUS THERAPEUTICS, INC.
Exercise(M)Direct8.1K shares- - May 14, 2026PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
23.8K shares- - May 14, 2026PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
23.8K shares- - Apr 1, 2026PSTV
PLUS THERAPEUTICS, INC.
Exercise(M)Direct201.6K shares- - Apr 1, 2026PSTV
PLUS THERAPEUTICS, INC.
Exercise(M)Direct159.7K shares- - Feb 25, 2026PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
2.4M shares- - Feb 25, 2026PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
2.4M shares- - Jan 1, 2026PSTV
PLUS THERAPEUTICS, INC.
Exercise(M)Direct159.7K shares- - Oct 1, 2025PSTV
PLUS THERAPEUTICS, INC.
Exercise(M)Direct159.7K shares- - Aug 13, 2025PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
1.9M shares- - Aug 13, 2025PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
5.7M shares- - Aug 13, 2025PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
5.7M shares- - Aug 13, 2025PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
1.9M shares- - Feb 18, 2025PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
400.5K shares- - Sep 11, 2024PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
197.6K shares- - Sep 10, 2024PSTV
PLUS THERAPEUTICS, INC.
Purchase(P)Direct8K shares at avg. $1.23$10K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | CNSY CERENOME, INC. | Exercise(M) | 1,986 | - | $0 | Direct |
| Oct 1, 2026 | CNSY CERENOME, INC. | Exercise(M) | 8,066 | - | $0 | Direct |
| Oct 1, 2026 | CNSY CERENOME, INC. | Exercise(M) | 6,387 | - | $0 | Direct |
| Jul 1, 2026 | PSTV PLUS THERAPEUTICS, INC. | Exercise(M) | 1,986 | - | $0 | Direct |
| Jul 1, 2026 | PSTV PLUS THERAPEUTICS, INC. | Exercise(M) | 6,387 | - | $0 | Direct |
| Jul 1, 2026 | PSTV PLUS THERAPEUTICS, INC. | Exercise(M) | 8,066 | - | $0 | Direct |
| May 14, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 23,834 | - | - | Direct |
| May 14, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Restricted Stock Units | 23,834 | - | - | Direct |
| Apr 1, 2026 | PSTV PLUS THERAPEUTICS, INC. | Exercise(M) | 201,632 | - | $0 | Direct |
| Apr 1, 2026 | PSTV PLUS THERAPEUTICS, INC. | Exercise(M) | 159,681 | - | $0 | Direct |
| Feb 25, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 2,419,582 | - | - | Direct |
| Feb 25, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Restricted Stock Units | 2,419,582 | - | - | Direct |
| Jan 1, 2026 | PSTV PLUS THERAPEUTICS, INC. | Exercise(M) | 159,681 | - | $0 | Direct |
| Oct 1, 2025 | PSTV PLUS THERAPEUTICS, INC. | Exercise(M) | 159,681 | - | - | Direct |
| Aug 13, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Restricted Stock Units | 1,916,168 | - | - | Direct |
| Aug 13, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 5,748,506 | - | - | Direct |
| Aug 13, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 5,748,506 | - | - | Direct |
| Aug 13, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Restricted Stock Units | 1,916,168 | - | - | Direct |
| Feb 18, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 400,489 | - | - | Direct |
| Sep 11, 2024 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 197,595 | - | - | Direct |
| Sep 10, 2024 | PSTV PLUS THERAPEUTICS, INC. | Purchase(P) | 8,000 | $1.23 | $9,839 | Direct |
1-21 of 21 transactions
About HEDRICK MARC H
HEDRICK MARC H (SEC CIK 0001203672) files insider reports with the SEC as Chief Executive Officer of CERENOME, INC. (CNSY).
Signal8 holds 12 ownership filings by HEDRICK MARC H, all Form 4s, filed between Sep 11, 2024 and Oct 1, 2026. Those filings report 21 transactions, from Sep 10, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HEDRICK MARC H's filings is in HOUSTON, TX.
Recent filings by HEDRICK MARC H
- Oct 1, 2026: Option exercises of CNSY shares (3 lines, Form 4, code M).
- Jul 1, 2026: Option exercises of PSTV shares (3 lines, Form 4, code M).
- May 14, 2026: Grants or awards of PSTV derivative securities (2 lines, Form 4, code A).
- Apr 1, 2026: Option exercises of PSTV shares (2 lines, Form 4, code M).
- Feb 25, 2026: Grants or awards of PSTV derivative securities (2 lines, Form 4, code A).
Other insiders filing for CERENOME, INC. (CNSY)
- van Es-Johansson An, Director
- Hawkins Richard J, Director
- Clowes Howard, Director
- Sims Andrew John Hugh MacIntyre, Chief Financial Officer
- ANDREWS RONALD ASBURY, Director
- Guse Kyle, Director